What the GSK-Pfizer merger means for their Indian units2 min read . Updated: 20 Dec 2018, 09:52 AM IST
The positive changes effected by the GSK-Pfizer merger do not automatically trickle down to Indian subsidiaries
Investors are excited about GlaxoSmithKline Plc’s (GSK) plan to split the firm into two entities—pharmaceuticals and consumer healthcare. The consumer healthcare arm has been given heft through its merger with Pfizer Inc.’s consumer business.
Select your Category